The near term prospects for PRAN include:
1. The Removal of the PCH
2. The Start of the Phase 3 trial for Pbt2 in HD
3. Partnership Agreement
Prospect number 3 above is a real possibility as we go into phase 3 trial for HD. It would result in significant up-front money, Milestone payments, the payment of all development costs going forward, and Royalties on net sales. For PRAN such a deal would launch the share price. I consider today's price a gift if these prospects become fact. Note that PRAN may partners any one of its prospects including the pre-clinical prospects Pbt434 and Pbt519 which would result in less up-front money but would take care of development costs and add milestone payments. Also note that Professor Tanzi is likely to publish the results of Pbt2 in his "brain in a dish" experiment which he wrote about in his letter to shareholders at the AGM. There is much to look forward to and the time is near!!!
I just now put Copper and Bioinvest on Ignore and it really cleaned up my board. What they say is irrelevant!!! Paid bashers likely get paid by the number of posts which get replies. Just put them on Ignore and let them talk to themselves!!
Here is the actual post from that poster on the Australian HotCopper message board:
Yes, thanks for that IBBY and ditto to ITM's remark.
" I have just spoken to Geoffrey Kempler and he assured me that the ONLY thing that has changed is the share price.
Everything is progressing as advised at the AGM. I certainly have no reason for concern and am assured that the Co is steadily working toward the goals set.
If you are a shareholder he will happily return your call, as he did mine.
Good luck with your holding."